
Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows
–Revvity, Inc. (NYSE: RVTY), today announced the launch of three Mimix™ reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays…













